Skip to main content
. 2016 May 17;6:26241. doi: 10.1038/srep26241

Figure 1. LCA decreased cell viability and increased LDH release in NSCLC cells while not in normal cells.

Figure 1

(A) A549, NCI-H1299, and HELF cells were treated with indicated concentrations of LCA for 24 h. The cell viability was evaluated by MTT assay. *P < 0.05, **P < 0.01, compared with 0 μM LCA treatment. (B) Cells were treated with 0, 5, 10, 15, and 20 μM LCA for 24 h, and the LDH release was determined according to the manufacturer’s introductions. *P < 0.05 and **P < 0.01, compared with 0 μM LCA treatment.